TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/14/21 08:01 | 10/13/21 | AGRX | Agile Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Reilly Dennis | NJ | O | CFO | P.d | 0 | 0.00 | 0 | 59 | 23 | 310 | D | ||||||||||||||
7/28/21 20:57 | 7/27/21 | AGRX | Agile Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Reilly Dennis | NJ | O | CFO | P | 54 | 1.08 | 0 | 50 | 25 | 251 | D | ||||||||||||||
5/12/21 16:31 | 5/11/21 | AGRX | Agile Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Reilly Dennis | NJ | O | CFO | P | 27 | 1.35 | 0 | 20 | 11 | 201 | D | ||||||||||||||
3/23/21 17:23 | 3/23/21 | AGRX | Agile Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Reilly Dennis | NJ | O | CFO | P | 103 | 2.05 | 0 | 50 | 38 | 181 | D | ||||||||||||||
9/28/20 16:10 | 9/28/20 | AGRX | Agile Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Reilly Dennis | NJ | O | CFO | P | 26 | 2.85 | 0 | 9 | 7 | 131 | D | ||||||||||||||
3/6/20 08:00 | 3/4/20 | AGRX | Agile Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Reilly Dennis | NJ | O | CFO | P | 175 | 2.33 | 0 | 75 | 765 | 85 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |